RecallDepth
Class I Terminated

Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.

Company
Taro Pharmaceuticals U.S.A., Inc.
Recall Initiated
December 20, 2019
Posted
February 19, 2020
Recall Number
D-0833-2020
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Hawthorne, NY, United States

Reason for Recall

Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.

Distribution

Nationwide in the U.S. and Puerto Rico.

Lot / Code Info

Lot #: 331771, Exp. June 2021

More recalls by Taro Pharmaceuticals U.S.A., Inc.

View all recalls by this company →

Other recent Class I Drug recalls